StockData
Disc Medicine, Inc. logo

Disc Medicine, Inc. (IRON) stock

IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$76.57−0.02 (-0.03%)

Close on Nov 17, 2026Market cap $2.94BP/E –Yield –

Disc Medicine enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Disc Medicine's enterprise value was $2.62B on Nov 11, 2026, against $2.65B a year earlier. Over the last 5 years it ranged from -$75.84M to $2.65B, with a median of $986.03M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.62B+21.1%
2025Dec 31, 2025$2.16B+54.7%
2024Dec 31, 2024$1.40B+36.6%
2023Dec 29, 2023$1.02B+27.1%
2022Dec 30, 2022$805.58M-27.0%
2021Dec 31, 2021$1.10B–

More Disc Medicine figures

See a number that looks wrong?